Synergistic Combination of Bioengineered MicroRNA and Chemotherapy Across High-Risk Neuroblastoma Subtypes
이윤영, Albatool AlKhazal, Kathleen E. Doyle…·Erin G. Brown
This study evaluates bioengineered microRNA therapies combined with low-dose chemotherapy to treat high-risk neuroblastoma, showing improved efficacy and reduced toxicity.